Titan Pharmaceuticals
TTNP
#10417
Rank
C$8.41 M
Marketcap
C$6.33
Share price
-3.76%
Change (1 day)
35.99%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -C$3.92 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$6.46 Million, an increase over its 2023 earnings that were of -C$7.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$3.92 Million-39.42%
2024 -C$6.46 Million-15.5%
2023 -C$7.65 Million-45.43%
2022 -C$14.01 Million16.29%
2021 -C$12.05 Million-907.36%
2020 C$1.49 M-106.6%
2019 -C$22.6 Million82.4%
2018 -C$12.39 Million-36.93%
2017 -C$19.64 Million-378.62%
2016 C$7.04 M-145.53%
2015 -C$15.49 Million369.37%
2014 -C$3.3 Million-125.9%
2013 C$12.73 M-177.74%
2012 -C$16.39 Million13.59%
2011 -C$14.43 Million74.37%
2010 -C$8.28 Million3.61%
2009 -C$7.99 Million
2007 -C$25.31 Million12.08%
2006 -C$22.58 Million-28.65%
2005 -C$31.65 Million-10.03%
2004 -C$35.17 Million-6.08%
2003 -C$37.45 Million-14.76%
2002 -C$43.93 Million32.52%
2001 -C$33.15 Million27.55%
2000 -C$25.99 Million62.5%
1999 -C$16 Million4.04%
1998 -C$15.38 Million49.33%
1997 -C$10.3 Million-27.88%
1996 -C$14.28 Million13.04%
1995 -C$12.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-C$0.17 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$16.48 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.36 Billion 9,035.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.46 B-1,155,037.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.53 B-585,447.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
C$35.88 M-1,031.98%๐Ÿ‡บ๐Ÿ‡ธ USA